Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Arteries and veins have different types of endothelium but it is unclear how these molecular and functional differences are specified during development.

To understand more, Ludwig Oxford’s Alice Neal and colleagues from Sarah De Val’s group studied venous development in mice and zebrafish. They found that BMP signalling is required for transcriptional activation of the key venous regulator Ephb4 and subsequent establishment of venous blood vessels. This work, published in Nature Communications, therefore identifies a new potential target for anti-angiogenic therapy to reduce tumour growth.